MicroRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2021 Feb 8

PMID 33550941

Citations 4

Authors

Gaolian Zhang

Meng Xia

Jianhui Guo

Yi Huang

Jianrong Huang

Kecong Wei

Xiaoning Zhang

Jing Zeng

Weibin Liang

Affiliations

Soon will be listed here.

Abstract

Aberrant expression of microRNAs (miRNAs) has been reported to play a role in tumorigenesis. Dysfunction of miR-1296 was found in a variety of cancers, however, the function of miR-1296 in the progression of glioma remains largely understood. Here, our results showed that miR-1296 was significantly down-regulated in glioma tissues and cell lines. Decreased expression of miR-1296 was associated with the tumor size, WHO grade and karnofsky performance scale (KPS) of glioma patients. Low expression of miR-1296 was significantly correlated with the shorter 5-year overall survival of glioma patients. Overexpression of miR-1296 inhibited the proliferation, colony formation, migration and induced apoptosis of glioma cells. MiR-1296 was found to bind the 3'-untranslated region (UTR) of ABL proto-oncogene 2 (ABL2) and subsequently repressed both the mRNA and protein expression of ABL2. ABL2 was overexpressed in glioma tissues and inversely correlated with that of miR-1296. Ectopic expressed ABL2 could reverse the inhibitory effects of miR-1296 on glioma cell proliferation. Our results illustrated the novel tumor-suppressive function of miR-1296 in glioma via repressing ABL2, suggesting a potential application of miR-1296 in the treatment of glioma.

Citing Articles

miR-769-3p inhibits cellular proliferation of KSHV-infected SH-SY5Y cells through targeting mTOR.

Cao D, Wu Z, Yang R, Yao L, Huang J, Ding Y J Cancer. 2024; 15(11):3338-3349.

PMID: 38817860 PMC: 11134426. DOI: 10.7150/jca.93595.

Interaction among long non-coding RNA, micro-RNA and mRNA in glioma.

Chai Y, Liu S, Xie M Ibrain. 2023; 7(2):141-145.

PMID: 37786911 PMC: 10528991. DOI: 10.1002/j.2769-2795.2021.tb00076.x.

Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.

Miao Y, Liu J Clin Transl Oncol. 2023; 26(2):398-413.

PMID: 37479901 DOI: 10.1007/s12094-023-03255-w.

FXR1 promotes glioma progression by downregulating microRNA-124-3p through long noncoding RNA FGD5-AS1 upregulation.

Gong X, Huang M, Chen L, Zeng H Acta Neurol Belg. 2023; 123(4):1453-1464.

PMID: 37074635 DOI: 10.1007/s13760-023-02263-5.

References

Khatri A, Wang J, Pendergast A . Multifunctional Abl kinases in health and disease. J Cell Sci. 2016; 129(1):9-16. PMC: 4732293. DOI: 10.1242/jcs.175521. View

Liu S, Yin F, Zhang J, Wicha M, Chang A, Fan W . Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells. J Cell Biochem. 2014; 115(8):1368-80. DOI: 10.1002/jcb.24786. View

Gusyatiner O, Hegi M . Glioma epigenetics: From subclassification to novel treatment options. Semin Cancer Biol. 2017; 51:50-58. DOI: 10.1016/j.semcancer.2017.11.010. View

Rupaimoole R, Slack F . MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017; 16(3):203-222. DOI: 10.1038/nrd.2016.246. View

Pronin S, Koh C, Hughes M . Effects of Ultraviolet Radiation on Glioma: Systematic Review. J Cell Biochem. 2017; 118(11):4063-4071. DOI: 10.1002/jcb.26061. View

Mohr A, Mott J . Overview of microRNA biology. Semin Liver Dis. 2015; 35(1):3-11. PMC: 4797991. DOI: 10.1055/s-0034-1397344. View

Chen L, Zhu M, Yu S, Hai L, Zhang L, Zhang C . Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells. Exp Cell Res. 2020; 389(1):111893. DOI: 10.1016/j.yexcr.2020.111893. View

Greuber E, Smith-Pearson P, Wang J, Pendergast A . Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer. 2013; 13(8):559-71. PMC: 3935732. DOI: 10.1038/nrc3563. View

Hosseinahli N, Aghapour M, Duijf P, Baradaran B . Treating cancer with microRNA replacement therapy: A literature review. J Cell Physiol. 2018; 233(8):5574-5588. DOI: 10.1002/jcp.26514. View

10.

Wang J, Pendergast A . The Emerging Role of ABL Kinases in Solid Tumors. Trends Cancer. 2015; 1(2):110-123. PMC: 4669955. DOI: 10.1016/j.trecan.2015.07.004. View

11.

Li Y, Xu J, Zhang J, Zhang J, Zhang J, Lu X . MicroRNA-346 inhibits the growth of glioma by directly targeting NFIB. Cancer Cell Int. 2019; 19:294. PMC: 6857291. DOI: 10.1186/s12935-019-1017-5. View

12.

Kwak P, Iwasaki S, Tomari Y . The microRNA pathway and cancer. Cancer Sci. 2010; 101(11):2309-15. PMC: 11159795. DOI: 10.1111/j.1349-7006.2010.01683.x. View

13.

Qu H, Xu W, Huang Y, Yang S . Circulating miRNAs: promising biomarkers of human cancer. Asian Pac J Cancer Prev. 2011; 12(5):1117-25. View

14.

Deng H, Xie C, Ye Y, Du Z . MicroRNA-1296 expression is associated with prognosis and inhibits cell proliferation and invasion by Wnt signaling in non-small cell lung cancer. Oncol Lett. 2020; 19(1):623-630. PMC: 6924095. DOI: 10.3892/ol.2019.11154. View

15.

Majid S, Dar A, Saini S, Chen Y, Shahryari V, Liu J . Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010; 70(7):2809-18. DOI: 10.1158/0008-5472.CAN-09-4176. View

16.

Gong A, Ge N, Yao W, Lu L, Liang H . Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level. Cancer Chemother Pharmacol. 2014; 74(3):531-8. DOI: 10.1007/s00280-014-2534-5. View

17.

Momtazi A, Shahabipour F, Khatibi S, Johnston T, Pirro M, Sahebkar A . Curcumin as a MicroRNA Regulator in Cancer: A Review. Rev Physiol Biochem Pharmacol. 2016; 171:1-38. DOI: 10.1007/112_2016_3. View

18.

Jia Y, Zhao L, Bai H, Zhang C, Dai S, Lv H . The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer. Biosci Rep. 2018; 39(1). PMC: 6328896. DOI: 10.1042/BSR20181556. View

19.

Oberheim Bush N, Chang S, Berger M . Current and future strategies for treatment of glioma. Neurosurg Rev. 2016; 40(1):1-14. DOI: 10.1007/s10143-016-0709-8. View

20.

Farazi T, Spitzer J, Morozov P, Tuschl T . miRNAs in human cancer. J Pathol. 2010; 223(2):102-15. PMC: 3069496. DOI: 10.1002/path.2806. View